The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance
Open accessAbstract
Alterations in mitochondrial function have been implicated in the pathogenesis of insulin resistance and type 2 diabetes. However, it is unclear whether the reduced mitochondrial function is a primary or acquired defect in this process. To determine whether primary defects in mitochondrial β-oxidation can cause insulin resistance, we studied mice with a deficiency of long-chain acyl-CoA dehydrogenase (LCAD), a key enzyme in mitochondrial fatty acid oxidation. Here, we show that LCAD knockout mice develop hepatic steatosis, which is associated with hepatic insulin resistance, as reflected by reduced insulin suppression of hepatic glucose production during a hyperinsulinemic-euglycemic clamp. The defects in insulin action were associated with an ≈40% reduction in insulin-stimulated insulin receptor substrate-2-associated phosphatidylinositol 3-kinase activity and an ≈50% decrease in Akt2 activation. These changes were associated with increased PKCε activity and an aberrant 4-fold increase in diacylglycerol content after insulin stimulation. The increase in diacylglycerol concentration was found to be caused by de novo synthesis of diacylglycerol from medium-chain acyl-CoA after insulin stimulation. These data demonstrate that primary defects in mitochondrial fatty acid oxidation capacity can lead to diacylglycerol accumulation, PKCε activation, and hepatic insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent studies have shown that increased hepatocellular concentrations of diacylglycerol in nonalcoholic fatty liver disease lead to activation of the protein kinase C epsilon isoform, resulting in reduced insulin signaling and hepatic insulin resistance.23–27”
From Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease (2010) · cites this paper as [27]
In the citing paper
“There is now strong evidence that nonalcoholic fatty liver disease has an important role in causing hepatic insulin resistance.1–3,23–27”
From Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease (2010) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationImpaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Self-citationMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
Self-citationPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
Self-citationMechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Self-citationTranscriptional regulatory circuits controlling mitochondrial biogenesis and function
Kelly, D. P., & Scarpulla, R. C. (2004) · Genes & Development · doi:10.1101/gad.1177604 · Cited by 1,243
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232
Cited by
Sorted by citations
Items 101–200 of 290
Heat shock protein 72 regulates hepatic lipid accumulation
Archer, A. E., Rogers, R. S., Schulze, A. T. V., Wheatley, J. L., Morris, E. M., McCoin, C. S., Thyfault, J. P., & Geiger, P. C. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00073.2018 · Cited by 56
Endoplasmic reticulum-mitochondria calcium signaling in hepatic metabolic diseases
Rieusset, J. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.01.001 · Cited by 58
Item, F., Wueest, S., Lemos, V., Stein, S., Lucchini, F. C., Denzler, R., Fisser, M. C., Challa, T. D., Pirinen, E., Kim, Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00566-9 · Cited by 54
Valdecantos, M. P., Pérez‐Matute, P., González‐Muniesa, P., Prieto-Hontoria, P. L., Moreno-Aliaga, M. J., & Martínez, J. A. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.11.011 · Cited by 54
Type 2 diabetes, mitochondrial biology and the heart
Sack, M. N. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.001 · Cited by 53
Chow, L. S., From, A. H. L., & Seaquist, E. R. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.009 · Cited by 54
Reye Syndrome and Reye-Like Syndrome
Gosalakkal, J., & Kamoji, V. M. (2008) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2008.06.003 · Cited by 52
Pachikian, B., Neyrinck, A., Cani, P. D., Portois, L., Deldicque, L., de Backer, F. D., Bindels, L., Sohet, F., Malaisse, W., Francaux, M., et al. (2008) · BMC Physiology · doi:10.1186/1472-6793-8-21 · Cited by 49
Chen, Y., Varghese, Z., & Ruan, X. Z. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.07.007 · Cited by 54
Kim, Y., Choi, M., Woo, J. T., Jeong, M. J., Kim, S. R., & Jung, U. J. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600889 · Cited by 50
Insulin resistance in critical illness
Dhar, A. V., & Castillo, L. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283464b3e · Cited by 50
Changes in body composition and metabolic disease risk
Pi-Sunyer, X. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0320-x · Cited by 53
The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
Chew, N., Chong, B., Ng, C. H., Kong, G., Chin, Y. H., Xiao, W., Lee, C. J. M., Dan, Y. Y., Muthiah, M. D., & Foo, R. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.971484 · Cited by 49
Geng, T., Hu, W. M., Broadwater, M. H., Snider, J. M., Bielawski, J., Russo, S. B., Schwacke, J. H., Ross, J. S., & Cowart, L. A. (2013) · Diabetologia · doi:10.1007/s00125-013-2973-2 · Cited by 50
Henriksen, B. S., Curtis, M. E., Fillmore, N., Cardon, B. R., Thomson, D. M., & Hancock, C. R. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-29 · Cited by 49
Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?
Finck, B. N., & Hall, A. M. (2015) · BioMed Research International · doi:10.1155/2015/104132 · Cited by 47
Pan, Y., Zhao, W., Zhao, D., Wang, C., Yu, N., An, T., Mo, F., Liu, J., Miao, J., Lv, B., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00671 · Cited by 47
Genetic variants in candidate genes influencing NAFLD progression
Rosa, M. D., & Malaguarnera, L. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0803-x · Cited by 47
Obesity III: Obesogen assays: Limitations, strengths, and new directions
Kassotis, C. D., Saal, F. S. V., Babin, P. J., Lagadic‐Gossmann, D., Mentec, H. L., Blumberg, B., Mohajer, N., Legrand, A., Kos, V. M., Martin‐Chouly, C., et al. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115014 · Cited by 49
Liver mitochondria and insulin resistance.
Vial, G., Dubouchaud, H., & Leverve, X. M. (2010) · Acta Biochimica Polonica · doi:10.18388/abp.2010_2422 · Cited by 42
Baig, M. R., Navaira, E., Escamilla, M., Raventós, H., & Walss‐Bass, C. (2010) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000388627.36781.6a · Cited by 41
Deminice, R., de Castro, G. S. F., Francisco, L. V., da Silva, L. E. C. M., Cardoso, J. F. R., Frajacomo, F. T. T., Teodoro, B. G., dos Reis Silveira, L., & Jordao, A. A. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.11.014 · Cited by 39
Herrema, H., Derks, T. G. J., van Dijk, T. H., Bloks, V. W., Gerding, A., Havinga, R., Tietge, U. J. F., Müller, M. M., Smit, P. G. A., Kuipers, F., et al. (2008) · Hepatology · doi:10.1002/hep.22284 · Cited by 38
Wang, D. Q. ‐., Portincasa, P., & Neuschwander‐Tetri, B. A. (2013) · Comprehensive physiology · doi:10.1002/cphy.c130001 · Cited by 41
Yao, H., Wang, Y., Zhang, X., Li, P., Shang, L., Chen, X., & Zeng, J. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102845 · Cited by 39
Verma, S., Shankar, E., Chan, E. R., & Gupta, S. (2020) · Cells · doi:10.3390/cells9122535 · Cited by 38
Exploiting Common Aspects of Obesity and Alzheimer’s Disease
Tabassum, S., Misrani, A., & Yang, L. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.602360 · Cited by 36
Niu, T.-H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i13.3655 · Cited by 38
Liu, S., Chiu, C., Shi, C.-M., & Chiang, M. (2018) · Marine Drugs · doi:10.3390/md16080251 · Cited by 35
Dhurandhar, E. J., Krishnapuram, R., Hegde, V. K., Dubuisson, O. S., Tao, R., Dong, X. C., Ye, J., & Dhurandhar, N. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047813 · Cited by 35
Defining lipid mediators of insulin resistance: controversies and challenges
Metcalfe, L. K., Smith, G. C., & Turner, N. A. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0023 · Cited by 35
Fritsch, M., Koliaki, C., Livingstone, R., Phielix, E., Bierwagen, A., Meisinger, M., Jelenik, T., Strassburger, K., Zimmermann, S., Brockmann, K., et al. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.107599 · Cited by 33
Mitochondria and diabetes mellitus: untangling a conflictive relationship?
Schiff, M., Loublier, S., Coulibaly, A., Bénit, P., de Baulny, H. O., & Rustin, P. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1263-0 · Cited by 31
Kärst, S., Cheng, R., Schmitt, A. O., Yang, H., de Villena, F. P., Palmer, A. A., & Brockmann, G. A. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9342-6 · Cited by 32
Lei, L., Zhu, Y., Gao, W., Du, X., Zhang, M., Peng, Z., Fu, S., Li, X., Zhe, W., Li, X. G., et al. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.06.024 · Cited by 32
Tushuizen, M. E., Pouwels, P. J. W., Bontemps, S., Rustemeijer, C., Matikainen, N., Heine, R. J., Taskinen, M., & Diamant, M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.002 · Cited by 30
Zhou, W., Rahimnejad, S., Tocher, D. R., Lu, K., Zhang, C., & Sun, Y. (2018) · Aquaculture · doi:10.1016/j.aquaculture.2018.09.028 · Cited by 31
Do flavanols-rich natural products relieve obesity-related insulin resistance?
Engin, A. B., Tsatsakis, A. M., Tsoukalas, D., & Engin, A. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.12.055 · Cited by 30
Nyman, L. R., Tian, L., Hamm, D. A., Schoeb, T. R., Gower, B. A., Nagy, T. R., & Wood, P. A. (2011) · Nutrition and Diabetes · doi:10.1038/nutd.2011.11 · Cited by 29
Self-citationPilvi, T. K., Seppänen‐Laakso, T., Simolin, H., Finckenberg, P., Huotari, A., Herzig, K., Korpela, R., Orešič, M., & Mervaala, E. M. A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4462 · Cited by 28
Zhang, Z., Chen, J., Zhou, S., Wang, S., Cai, X., Conklin, D. J., Kim, K.-S., Kim, K. H., Tan, Y., Zheng, Y., et al. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.12101 · Cited by 27
Selenium and Selenoproteins at the Intersection of Type 2 Diabetes and Thyroid Pathophysiology
Gorini, F., & Vassalle, C. (2022) · Antioxidants · doi:10.3390/antiox11061188 · Cited by 30
Shi, W., Zhu, Q., Gu, J., Liu, X., Lü, L., Qian, X., Shen, J., Zhang, F., & Li, G. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/253046 · Cited by 27
Modeling Disorders of Fatty Acid Metabolism in the Mouse
Goetzman, E. S. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00010-8 · Cited by 25
Hu, X., Duan, Z., Hu, H., Li, G., Yan, S., Wu, J., Wang, J., Yin, D., & Xie, Q. (2013) · PROTEOMICS · doi:10.1002/pmic.201200522 · Cited by 25
Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis
Engin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_18 · Cited by 28
Kim, H., Lee, E. Y., Lee, B., Yadav, D., Kim, Y. M., Ko, H., Park, K., Lee, E. Y., & Chung, C. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120711 · Cited by 25
Gillingham, M. B., Harding, C. O., Schoeller, D. A., Matern, D., & Purnell, J. Q. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00225.2013 · Cited by 25
Ussher, J. R., Keung, W., Fillmore, N., Koves, T. R., Mori, J., Zhang, L., Lopaschuk, D. G., Ilkayeva, O., Wagg, C. S., Jaswal, J. S., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214197 · Cited by 24
Valencia, A. P., Schappal, A. E., Morris, E. M., Thyfault, J. P., Lowe, D. A., & Spangenburg, E. E. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.11.011 · Cited by 24
Chen, Y., Chen, J., Zhang, C., Yang, S., Zhang, X., Liu, Y., & Su, Z. (2019) · The FASEB Journal · doi:10.1096/fj.201901474rr · Cited by 23
Yoshino, S., Satoh, T., Yamada, M., Hashimoto, K., Tomaru, T., Katano-Toki, A., Kakizaki, S., Okada, S., Shimizu, H., Ozawa, A., et al. (2014) · Endocrinology · doi:10.1210/en.2013-2160 · Cited by 22
Goda, K., Kobayashi, A., Takahashi, A., Takahashi, T., Saito, K., Maekawa, K., Saito, Y., & Sugai, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040810 · Cited by 22
Ramachandran, D., Clara, R., Fedele, S., Hu, J., Lackzo, E., Huang, J.-Y., Verdin, E. M., Langhans, W., & Mansouri, A. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.07.009 · Cited by 23
Maseko, T., Elkalaf, M., Peterová, E., Lotková, H., Staňková, P., Melek, J., Dušek, J., Žádníková, P., Čížková, D., Bezrouk, A., et al. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5342 · Cited by 21
The emerging significance of mitochondrial targeted strategies in NAFLD treatment
Zhang, T., Nie, Y., & Wang, J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121943 · Cited by 21
Yan, X., Zhuo, Y., Bian, X., Li, J., Zhang, Y., Ma, L., Lu, G., Guo, M., Wu, J., & Li, N. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00350 · Cited by 21
Inborn errors of mitochondrial acyl-coenzyme a metabolism: acyl-CoA biology meets the clinic
Yang, H., Zhao, C., Tang, M.-C., Wang, Y., Wang, S. P., Allard, P., Fürtös, A., & Mitchell, G. A. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2019.05.002 · Cited by 20
Yang, C., Zhu, Y., Ding, Y., Huang, Z., Dan, X., Shi, Y., & Kang, X. (2021) · Gene · doi:10.1016/j.gene.2021.145934 · Cited by 22
Protein kinase Cε: the mitochondria‐mediated signaling pathway
Yonekawa, H., & Akita, Y. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06558.x · Cited by 20
Atsuzawa, K., Nakazawa, A., Mizutani, K., Fukasawa, M., Yamamoto, N., Hashimoto, T., & Usuda, N. (2010) · Histochemistry and Cell Biology · doi:10.1007/s00418-010-0752-4 · Cited by 20
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch13 · Cited by 20
Self-citationLv, B., Bao, X., Li, P., Lian, J., Wu, Y., An, T., Zhang, J., Yang, X., Wang, T., Zhu, J., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.558344 · Cited by 20
McGinnis, C. D., Jennings, E. Q., Harris, P. S., Galligan, J. J., & Fritz, K. S. (2022) · Cells · doi:10.3390/cells11132045 · Cited by 18
Chen, B., Xiao, W., Zou, Z., Zhu, J., Li, D., Yu, J., & Yang, H. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.879570 · Cited by 18
Batran, R. A., Gopal, K., Aburasayn, H., Eshreif, A., Almutairi, M. G., Greenwell, A. A., Campbell, S. A., Saleme, B., Court, E. A., Eaton, F., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124643 · Cited by 18
Li, L., Wang, L., Wang, T.-L., & Zheng, F.-M. (2023) · Medical Oncology · doi:10.1007/s12032-023-01978-y · Cited by 17
Ling, F., Fan, Y., Wang, Z., Xie, N., Li, J., Wang, G., & Feng, J. (2023) · BMC Genomics · doi:10.1186/s12864-023-09317-1 · Cited by 17
Mengr, A., Strnadová, V., Strnad, Š., Vrkoslav, V., Pelantová, H., Kuzma, M., Comptdaer, T., Železná, B., Kuneš, J., Galas, M., et al. (2023) · Nutrients · doi:10.3390/nu15173690 · Cited by 17
Deng, Z., Yan, S., Hu, H., Duan, Z., Yin, L., Liao, S., Sun, Y., Yin, D., & Li, G. (2014) · PROTEOMICS · doi:10.1002/pmic.201400115 · Cited by 17
Machida, K. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7241 · Cited by 18
Enzymatically synthesized glycogen reduces lipid accumulation in diet-induced obese rats
Furuyashiki, T., Ogawa, R., Nakayama, Y., Honda, K., Kamisoyama, H., Takata, H., Yasuda, M. T., Kuriki, T., & Ashida, H. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.06.006 · Cited by 17
Physiological and pathophysiological actions of insulin in the liver
Kubota, N., Kubota, T., & Kadowaki, T. (2025) · Endocrine Journal · doi:10.1507/endocrj.ej24-0192 · Cited by 19
Li, T., Jin, M., Fei, X., Yuan, Z., Wang, Y., Quan, K., Wang, T., Yang, J., He, M., & Wei, C. (2022) · Animals · doi:10.3390/ani12131650 · Cited by 16
Gong, H., Xu, H., Li, M., & Zhang, D. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175325 · Cited by 16
Self-citationGaston, G. D., Babcock, S. J., Ryals, R. C., Elizondo, G., DeVine, T., Wafai, D., Packwood, W. H., Holden, S. J., Raber, J., Lindner, J. R., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05268-1 · Cited by 16
Genovese, S., Ashida, H., Yamashita, Y., Nakgano, T., Ikeda, M., Shirasaya, D., Epifano, F., Taddeo, V. A., & Fiorito, S. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.06.005 · Cited by 16
Bhowmick, S., Singh, V., Jash, S., Lal, M., & Roy, S. S. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.01.007 · Cited by 16
Mungamuri, S. K., Sinha, S. N., & Javvadi, Y. (2020) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2020035839 · Cited by 17
Urasaki, Y., Fiscus, R. R., & Le, T. T. (2016) · The Journal of Pathology · doi:10.1002/path.4685 · Cited by 16
mTORC1 activation is not sufficient to suppress hepatic PPARα signaling or ketogenesis
Alpergin, E. S. S., & Wolfgang, M. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100884 · Cited by 15
MicroRNA-126b-5p Exacerbates Development of Adipose Tissue and Diet-Induced Obesity
Shen, L., He, J., Zhao, Y., Niu, L., Chen, L., Tang, G., Jiang, Y., Hao, X., Bai, L., Li, X., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910261 · Cited by 15
Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease
Wang, C., Gong, J., & Wu, H. (2017) · Biomedical Reports · doi:10.3892/br.2017.926 · Cited by 14
Lv, H., Wang, Y., Liu, J., Zhen, C., Zhang, X., Liu, Y., Lou, C., Guo, H., & Wei, Y. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166719 · Cited by 14
Kulsange, S. E., Sharma, M., Sonawane, B. R., Jaiswal, M. R., Kulkarni, M. J., & Santhakumari, B. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.114667 · Cited by 13
Hsu, K.-L., Fan, H.-J., Chen, Y., Huang, Y., Chen, C.-H., Wu, J., & Wang, S. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.12.016 · Cited by 13
Increased mortality from influenza infection in long-chain acyl-CoA dehydrogenase knockout mice
Shinde, A., Luo, J., Bharathi, S. S., Shi, H., Beck, M. E., McHugh, K. J., Alcorn, J. F., Wang, J., & Goetzman, E. S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.135 · Cited by 13
Zhao, L., Cheng, Y., Li, B., Gu, X., Zhang, X., Boateng, N. A. S., & Zhang, H. (2019) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.9844 · Cited by 13
Signal transduction in inherited metabolic disorders: a model for a possible pathogenetic mechanism
Boneh, A. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9820-1 · Cited by 13
Metabolic pathways at the crossroads of diabetes and inborn errors
Goetzman, E. S., Gong, Z., Schiff, M., Wang, Y., & Muzumdar, R. H. (2017) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0091-x · Cited by 16
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch17 · Cited by 14
Self-citationCao, Y., Wang, Y., Zhao, N., Yuan, Z., Zhang, L. H., & Jin, P. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156356 · Cited by 11
Proteomic analysis of adipose tissue: informing diabetes research
Murri, M., Insenser, M. R., Luque‐Ramírez, M., Tinahones, F. J., & Escobar-Morreale, H. F. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2014.903158 · Cited by 11
Zhao, T., Ding, S., Hao, Z., Wang, X., Zhan, Y., & Chang, Y. (2021) · Genomics · doi:10.1016/j.ygeno.2021.05.040 · Cited by 11
Zacherl, J. R., Mihalik, S. J., Chace, D. H., Christensen, T. C., Robinson, L. J., & Blair, H. C. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24633 · Cited by 12
Lee, D., Shin, Y., Roh, J., Ahn, J., Jeong, S., Shin, S. C., & Yoon, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124256 · Cited by 11
RetractedDing, Y., Wan, Q., & Liu, W. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1615363 · Cited by 12
Elucidating Molecular Mechanisms of Drug-Induced Hepatotoxicity of Lapatinib
Yu, Q., Ma, L., Norona, L. M., Dragovich, P. S., Wang, J., Wang, S., Chen, Y.-C., Khojasteh, S. C., Kenny, J. R., Dean, B. J., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01305 · Cited by 10
Self-citationRole of acetylation in nonalcoholic fatty liver disease: a focus on SIRT1 and SIRT3
Nassir, F. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00017 · Cited by 10
Metabolic alterations in the critically ill child: a narrative review
Orellana, R. A., & Coss‐Bu, J. A. (2021) · Pediatric Medicine · doi:10.21037/pm-20-64 · Cited by 12
Metadata
- Authors
- Zhang, D., Liu, Z.-X., Choi, C. S., Tian, L., Kibbey, R., Dong, J., Cline, G. W., Wood, P. A., & Shulman, G. I.
- Affiliations
- Howard Hughes Medical Institute (US)
- *Howard Hughes Medical Institute and
- Departments of †Internal Medicine and
- University of Alabama at Birmingham (US)
- Corresponding author
- Shulman, Gerald I.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-10-23
- Volume
- 104
- Issue
- 43
- Pages
- 17075-17080
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2040460
- OpenAlex
- W2091450162
- Cited by
- 291
- References
- 27
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 10 · 2023: 22 · 2022: 14 · 2021: 11 · 2020: 9 · 2019: 14 · 2018: 13 · 2017: 19 · 2016: 15 · 2015: 19 · 2014: 25 · 2013: 15 · 2012: 22
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- U.S. Public Health Service (R01 DK-40936)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK40936, U24DK59635, R01DK040936, U24DK059635)
- National Center for Research Resources (R01-RR02599, R01RR002599)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- long-chain acyl-CoA dehydrogenase deficiency, mitochondrial dysfunction, hepatic steatosis, hepatic insulin resistance, mitochondrial fatty acid oxidation, insulin receptor substrate 2, phosphatidylinositol 3-kinase, AKT2, protein kinase C epsilon, diacylglycerol, type 2 diabetes
- MeSH terms
- Acyl Coenzyme A, Animals, Calorimetry, Carbon Isotopes, Diglycerides, Energy Metabolism, Fatty Liver, Gene Expression Regulation, Glucose, Homeostasis, Insulin, Insulin Resistance, Liver, Mitochondria, Oxidation-Reduction, Triglycerides, Signal Transduction, Muscle, Skeletal, Acyl-CoA Dehydrogenase, Long-Chain, Mice, Protein Kinase C-epsilon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
